Ipsen’s Cabometyx wins EU nod for liver cancer

15th November 2018 Uncategorised 0

Ipsen’s Cabometyx can now be used as monotherapy to treat certain patients with liver cancer following a green light from regulators in Europe.

More: Ipsen’s Cabometyx wins EU nod for liver cancer
Source: News